CABA – cabaletta bio, inc. (US:NASDAQ)
Stock Stats
News
Cabaletta Bio (CABA) had its price target lowered by Morgan Stanley from $14.00 to $13.00. They now have an "overweight" rating on the stock.
Cabaletta Bio (CABA) had its price target raised by Guggenheim from $15.00 to $16.00. They now have a "buy" rating on the stock.
Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Cabaletta Bio Highlights Pivotal Myositis Trial, No-Preconditioning CAR-T Push at TD Cowen Conference [Yahoo! Finance]
Form S-8 Cabaletta Bio, Inc.
Form 10-K Cabaletta Bio, Inc. For: Dec 31
Form 8-K Cabaletta Bio, Inc. For: Mar 23
Form 4 Cabaletta Bio, Inc. For: Mar 02 Filed by: Gerard Michael
Form 4 Cabaletta Bio, Inc. For: Mar 02 Filed by: Das Arun
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.